PT  - JOURNAL ARTICLE
AU  - Elizabeth A. Tracey
AU  - David M. Roder
AU  - Jane Francis
AU  - Helen M. Zorbas
AU  - Neville F. Hacker
AU  - James F. Bishop
TI  - Reasons for Improved Survival From Ovarian Cancer in New South Wales, Australia, Between 1980 and 2003: Implications for Cancer Control
AID  - 10.1111/IGC.0b013e3181a3a436
DP  - 2009 Apr 01
TA  - International Journal of Gynecologic Cancer
PG  - 591-599--591-599
VI  - 19
IP  - 4
4099  - http://ijgc.bmj.com/content/19/4/591-599.short
4100  - http://ijgc.bmj.com/content/19/4/591-599.full
SO  - Int J Gynecol Cancer2009 Apr 01; 19
AB  - We analyzed New South Wales Central Cancer Registry data for 1980-2003, to determine time trends in case fatality from ovarian cancer, after adjusting for stage, histological, and sociodemographic factors, and to consider service-delivery and research implications. After adjusting for covariates, the relative risk (95% confidence limit) of ovarian-cancer death reduced to 0.51 (0.46, 0.57) for 1999-2003 compared with 1980-1983. Relative risks were higher for adenocarcinomas and other specified and unspecified cancers than serous carcinomas, but lower for endometrioid carcinomas, sex cord-stromal and germ cell tumors. The probability of diagnosis with localized as opposed to more advanced disease was lower in older patients, the lowest socioeconomic stratum, women born in non-English-speaking countries, and more recent diagnostic periods. Approximately 61% of ovarian cancers had distant metastases at diagnosis in 1999-2003. Poorer survivals apply to older patients. Research directed at finding an effective screening test for epithelial ovarian cancer remains a priority.